Chison Medical Technologies Co., Ltd. (SHA:688358)
China
· Delayed Price · Currency is CNY 29.55
+0.77 (2.68%)
May 6, 2025, 2:45 PM CST
SHA:688358 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | 136.58 | 140.51 | 146.48 | 105.84 | 112.47 | 99.64 | Upgrade
|
| Depreciation & Amortization | 14.78 | 14.78 | 13.72 | 13.03 | 9.89 | 8.19 | Upgrade
|
| Other Amortization | 0.26 | 0.26 | 0.58 | 0.13 | 0.24 | 0.24 | Upgrade
|
| Loss (Gain) From Sale of Assets | -4.61 | -4.61 | -3.02 | 0.5 | -30.25 | -0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 4.39 | 4.39 | 0.06 | 0.51 | 1.58 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -6.12 | -6.12 | -11.17 | -15 | -17.53 | -27.22 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 3.58 | -1.4 | 0.74 | 1.13 | Upgrade
|
| Other Operating Activities | -21.15 | -19.77 | -19.06 | -15.19 | 6.22 | 3.25 | Upgrade
|
| Change in Accounts Receivable | -1.01 | -1.01 | -78.87 | 37.02 | -1.55 | -27.14 | Upgrade
|
| Change in Inventory | 5.65 | 5.65 | 56.08 | -100.41 | -16.76 | -25.41 | Upgrade
|
| Change in Accounts Payable | 7.83 | 7.83 | -20.33 | 41.92 | -25.33 | 48.33 | Upgrade
|
| Change in Other Net Operating Assets | -2.03 | -2.03 | -2.92 | -0.82 | 1.37 | 2.44 | Upgrade
|
| Operating Cash Flow | 135.38 | 140.68 | 85.91 | 63.74 | 39.96 | 82.45 | Upgrade
|
| Operating Cash Flow Growth | 24.25% | 63.76% | 34.78% | 59.51% | -51.53% | 3.28% | Upgrade
|
| Capital Expenditures | -8.59 | -8.85 | -34.01 | -52.21 | -39.19 | -30.88 | Upgrade
|
| Sale of Property, Plant & Equipment | 6.2 | 5.01 | 3.71 | 0.09 | 21.17 | 0.06 | Upgrade
|
| Investment in Securities | 543.57 | 535.7 | -236.03 | - | 165 | -745 | Upgrade
|
| Other Investing Activities | 14.4 | 23.68 | 25.15 | 6.69 | 17.1 | 27.22 | Upgrade
|
| Investing Cash Flow | 555.59 | 555.53 | -241.18 | -45.43 | 164.09 | -748.61 | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.95 | -0.93 | -0.61 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -0.95 | -0.93 | -0.61 | - | Upgrade
|
| Issuance of Common Stock | - | - | - | 2.02 | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | -10.1 | - | - | - | Upgrade
|
| Common Dividends Paid | -89.5 | -89.5 | -78.49 | -40 | -64 | -80 | Upgrade
|
| Other Financing Activities | -4.3 | -4.3 | - | - | - | -11.18 | Upgrade
|
| Financing Cash Flow | -93.8 | -93.8 | -89.53 | -38.91 | -64.61 | -91.18 | Upgrade
|
| Foreign Exchange Rate Adjustments | 10.63 | 12.24 | 9.34 | 21.59 | -2.99 | -3.62 | Upgrade
|
| Net Cash Flow | 607.79 | 614.64 | -235.47 | 0.99 | 136.45 | -760.95 | Upgrade
|
| Free Cash Flow | 126.78 | 131.83 | 51.9 | 11.53 | 0.78 | 51.56 | Upgrade
|
| Free Cash Flow Growth | 59.73% | 154.02% | 350.04% | 1386.91% | -98.50% | -28.42% | Upgrade
|
| Free Cash Flow Margin | 27.82% | 28.13% | 10.73% | 3.03% | 0.19% | 15.48% | Upgrade
|
| Free Cash Flow Per Share | 1.13 | 1.18 | 0.47 | 0.10 | 0.01 | 0.46 | Upgrade
|
| Cash Income Tax Paid | - | -2.42 | 0.48 | -6.43 | -14.31 | 0.43 | Upgrade
|
| Levered Free Cash Flow | 113.81 | 112.49 | -5.19 | -16.31 | 5.74 | 18.7 | Upgrade
|
| Unlevered Free Cash Flow | 113.81 | 112.49 | -4.97 | -16.24 | 5.78 | 18.7 | Upgrade
|
| Change in Net Working Capital | -39.22 | -36.31 | 54.18 | 18.58 | 10.31 | 12.66 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.